I AM BIOCT

Tanya Berbasova,
Kleo Pharmaceuticals

I AM BIOCT

Tanya Berbasova
Group Leader, Chemistry and Chemical Biology
Kleo Pharmaceuticals

Visit kleopharmaceuticals.com

JOIN BIOCT

Be part of a diverse community of innovators committed to the growth and sustainability our bioscience community.

Join Now

CAREER CENTER

Your source for today’s talent, job opportunities and career development.

Career Center

EXCLUSIVE DISCOUNTS

New England Edge, powered by MassBio, offers you substantial savings on the products and services you use the most.

Explore Offers

SPONSORSHIPS

Boost your visibility and show your support for Connecticut’s bioscience community.

Sponsorships

We are the voice of Connecticut’s bioscience industry.

Dedicated to the growth of a vibrant bioscience ecosystem, our organization connects companies, institutions, entrepreneurs, investors, government, service providers, and other passionate, dedicated people to improve patients’ lives and public health.

Upcoming Events

BIO CEO & Investor Conference

Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly...

2
Academic Bioscience R&D
4
Bioscience Patents
561
NIH Funding in 2018
4
Bioscience Venture Capital
8
Science & Engineering Doctorates

Your exclusive member benefits.

We’ve partnered with MassBio to bring you an even-bigger purchasing program featuring the supplier discounts their members enjoy.
Save big on everything you need, from travel to office products to lab supplies and more.

Click for Discounts

GOVERNMENT ADVOCACY

Your voice in Hartford
and Washington.

BioCT keeps policy makers abreast of the latest developments and changing needs of the bioscience community, ensuring policy alignment at the state and federal level.

Read More

Newsroom

Bayer and Azitra collaborate on skin bacteria

Bayer and Azitra have announced a joint development agreement to collaborate in the identification and characterization of skin microbiome bacteria. The partnership will leverage Azitra’s...

SpringWorks collaborates with Allogene re myeloma

SpringWorks Therapeutics has entered into a clinical trial collaboration agreement with Allogene Therapeutics.. This agreement will evaluate ALLO-715, Allogene’s investigational anti-B-cell maturation antigen (BCMA) AlloCAR...

CBX-12 is Cybrexa’s new lead development program

Cybrexa Therapeutics has announced CBX-12 (alphalexTM-exatecan) as its new lead development program. CBX-12 is an alphalexTM conjugate that includes the highly potent topoisomerase I inhibitor exatecan. CBX-12...